MedTrace Logo

Histology of Functional Density in Postmenopausal Breast

NCT01240278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-07-26

No results posted yet for this study

Summary

Increased mammographic density is recognized as an important risk factor for developing breast cancer, however, the underlying mechanism explaining this relationship is unclear. The investigators hypothesize that Molecular Breast Imaging (MBI) can more accurately distinguish dense tissue on mammography which is at high risk from dense tissue at low risk by indicating cellular activity in dense tissue as radiotracer uptake (functional density) in the breast. In this pilot study, the investigators want to compare the histological characteristics of breast tissue in patients with who have similar density on mammography but different levels of functional density on MBI.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Carrie Hruska, PhD · Mayo Clinic

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2022-04-27
Completion
2022-04-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01240278 on ClinicalTrials.gov